No abstract available
Keywords:
Editorials; coronary artery disease; eicosapentanoic acid; major adverse cardiovascular events.
MeSH terms
-
Animals
-
Atherosclerosis* / drug therapy
-
Atherosclerosis* / prevention & control
-
Cardiovascular Diseases / prevention & control
-
Dietary Supplements*
-
Eicosapentaenoic Acid* / administration & dosage
-
Eicosapentaenoic Acid* / analogs & derivatives
-
Eicosapentaenoic Acid* / therapeutic use
-
Humans